These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 21292918)

  • 1. Cyclooxygenase-2 expression is related with localization, proliferation, and overall survival in canine melanocytic neoplasms.
    Martínez CM; Peñafiel-Verdú C; Vilafranca M; Ramírez G; Méndez-Gallego M; Buendía AJ; Sánchez J
    Vet Pathol; 2011 Nov; 48(6):1204-11. PubMed ID: 21292918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COX-1 and COX-2 expression in canine cutaneous, oral and ocular melanocytic tumours.
    Pires I; Garcia A; Prada J; Queiroga FL
    J Comp Pathol; 2010; 143(2-3):142-9. PubMed ID: 20207364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proliferation activity in oral and cutaneous canine melanocytic tumours: correlation with histological parameters, location, and clinical behaviour.
    Millanta F; Fratini F; Corazza M; Castagnaro M; Zappulli V; Poli A
    Res Vet Sci; 2002 Aug; 73(1):45-51. PubMed ID: 12208106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of Ki67, BCL-2, and COX-2 in canine cutaneous mast cell tumors: association with grading and prognosis.
    Vascellari M; Giantin M; Capello K; Carminato A; Morello EM; Vercelli A; Granato A; Buracco P; Dacasto M; Mutinelli F
    Vet Pathol; 2013 Jan; 50(1):110-21. PubMed ID: 22673539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The histologic and epidemiologic bases for prognostic considerations in canine melanocytic neoplasia.
    Spangler WL; Kass PH
    Vet Pathol; 2006 Mar; 43(2):136-49. PubMed ID: 16537931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclooxygenase-2 expression is associated with infiltration of inflammatory cells in oral and skin canine melanomas.
    Silveira TL; Veloso ES; Gonçalves INN; Costa RF; Rodrigues MA; Cassali GD; Del Puerto HL; Pang LY; Argyle DJ; Ferreira E
    Vet Comp Oncol; 2020 Dec; 18(4):727-738. PubMed ID: 32323423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C-kit expression in canine mucosal melanomas.
    Newman SJ; Jankovsky JM; Rohrbach BW; LeBlanc AK
    Vet Pathol; 2012 Sep; 49(5):760-5. PubMed ID: 21825314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival of dogs following surgical excision of histologically well-differentiated melanocytic neoplasms of the mucous membranes of the lips and oral cavity.
    Esplin DG
    Vet Pathol; 2008 Nov; 45(6):889-96. PubMed ID: 18984791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fascin-1 expression in canine cutaneous and oral melanocytic tumours.
    Yamada N; Mori T; Murakami M; Noguchi S; Sakai H; Akao Y; Maruo K
    Vet Comp Oncol; 2012 Dec; 10(4):303-11. PubMed ID: 22236355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognosis after surgical excision of canine melanomas.
    Bostock DE
    Vet Pathol; 1979 Jan; 16(1):32-40. PubMed ID: 462717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of prognostic significance of angiogenesis in canine melanocytic tumours.
    Cuitiño MC; Massone AR; Idiart JR
    J Comp Pathol; 2012; 147(2-3):147-52. PubMed ID: 22520819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PCNA and Ki67 proliferation markers as criteria for prediction of clinical behaviour of melanocytic tumours in cats and dogs.
    Roels S; Tilmant K; Ducatelle R
    J Comp Pathol; 1999 Jul; 121(1):13-24. PubMed ID: 10373290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of mitotic index and Ki67 index in the prognostication of canine cutaneous mast cell tumours.
    Berlato D; Murphy S; Monti P; Stewart J; Newton JR; Flindall A; Maglennon GA
    Vet Comp Oncol; 2015 Jun; 13(2):143-50. PubMed ID: 23489679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. E-Cadherin Expression in Canine Melanocytic Tumors: Histological, Immunohistochemical, and Survival Analysis.
    Silvestri S; Porcellato I; Mechelli L; Menchetti L; Iussich S; De Maria R; Sforna M; Bongiovanni L; Brachelente C
    Vet Pathol; 2020 Sep; 57(5):608-619. PubMed ID: 32578507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic criteria for dogs with oral melanoma.
    Harvey HJ; MacEwen EG; Braun D; Patnaik AK; Withrow SJ; Jongeward S
    J Am Vet Med Assoc; 1981 Mar; 178(6):580-2. PubMed ID: 7263464
    [No Abstract]   [Full Text] [Related]  

  • 16. Canine melanoma diagnosis: RACK1 as a potential biological marker.
    Campagne C; Julé S; Alleaume C; Bernex F; Ezagal J; Château-Joubert S; Estrada M; Aubin-Houzelstein G; Panthier JJ; Egidy G
    Vet Pathol; 2013 Nov; 50(6):1083-90. PubMed ID: 23735618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigating associations of cyclooxygenase-2 expression with angiogenesis, proliferation, macrophage and T-lymphocyte infiltration in canine melanocytic tumours.
    Gregório H; Raposo TP; Queiroga FL; Prada J; Pires I
    Melanoma Res; 2016 Aug; 26(4):338-47. PubMed ID: 27105172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical expression of cyclooxygenage-2 in melanocytic skin lesions.
    Minami S; Lum CA; Kitagawa KM; Namiki TS
    Int J Dermatol; 2011 Jan; 50(1):24-9. PubMed ID: 21182498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of cyclooxygenase-2 in canine uveal melanocytic neoplasms.
    Paglia D; Dubielzig RR; Kado-Fong HK; Maggs DJ
    Am J Vet Res; 2009 Oct; 70(10):1284-90. PubMed ID: 19795944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical characterization and evaluation of prognostic factors in canine oral melanomas with osteocartilaginous differentiation.
    Sánchez J; Ramirez GA; Buendia AJ; Vilafranca M; Martinez CM; Altimira J; Navarro JA
    Vet Pathol; 2007 Sep; 44(5):676-82. PubMed ID: 17846240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.